Moore Capital Management’s AbbVie ABBV Stock Holding History

Moore Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-60,000	Closed	-$13.9M	–	667
2025 Q3	$13.9M	Sell	60,000 -40,000	-40%	-$8.15M	0.19%	111
2025 Q2	$18.6M	Buy	100,000 +55,000	+122%	+$10.2M	0.23%	89
2025 Q1	$9.43M	Buy	+45,000	New	+$8.75M	0.19%	111
2023 Q4	–	Sell	-60,000	Closed	-$8.94M	–	423
2023 Q3	$8.94M	Buy	+60,000	New	+$8.81M	0.17%	101
2022 Q1	–	Sell	-141,739	Closed	-$19.2M	–	745
2021 Q4	$19.2M	Buy	+141,739	New	+$16.7M	0.38%	50
2016 Q1	–	Sell	-36,243	Closed	-$2.15M	–	233
2015 Q4	$2.15M	Buy	+36,243	New	+$2.09M	0.07%	200
2015 Q3	–	Sell	-25,000	Closed	-$1.68M	–	277
2015 Q2	$1.68M	Buy	+25,000	New	+$1.63M	0.04%	320
2015 Q1	–	Sell	-30,044	Closed	-$1.82M	–	407
2014 Q4	$1.97M	Sell	30,044 -49,956	-62%	-$3.15M	0.06%	230
2014 Q3	$4.62M	Sell	80,000 -105,000	-57%	-$5.83M	0.11%	208
2014 Q2	$10.4M	Buy	+185,000	New	+$9.71M	0.25%	99

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Moore Capital Management's ABBV Position: Q4 2025 in Review

Moore Capital Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 60,000 shares — an estimated $13.9M sold.

Moore Capital Management first reported a position in ABBV in Q2 2014 and held it in 10 quarters. The position peaked at $19.2M in Q4 2021. 4,158 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Moore Capital Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Moore Capital Management sold 60,000 AbbVie shares in Q4 2025, an estimated $13.9M.
Moore Capital Management first reported a position in AbbVie in Q2 2014 and held it in 10 quarters.
Moore Capital Management's AbbVie position peaked at $19.2M in Q4 2021.
4,158 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Moore Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.